Skip to the reading
Sermorelin Then & Now

What adult Sermorelin studies actually found

A better-looking blood test isn’t always the change someone wanted in daily life. That’s the main thing to keep in mind here. Adult Sermorelin studies found hormone responses, but a hormone result needs its own explanation before treating it as a prediction about feeling better.

A man in his seventies extends one leg against a resistance band while seated in a bright recreation hall.

1992

A short adult study

The blood results moved

The 1992 Corpas trial studied healthy older men for two weeks. Sermorelin raised growth hormone and IGF-1, a growth factor made in response to it. At the higher trial dose, those measurements no longer differed from the younger comparison group’s.

That can sound like turning back the clock. It was a finding about blood hormones. The study didn’t establish longer life or lasting improvements in energy or weight. Matching a younger group on a blood test isn’t the same as becoming younger.

1997

Looking beyond hormone levels

More growth hormone didn’t mean less body fat

In the 1997 Vittone study, healthy older men received nightly Sermorelin for six weeks. Growth hormone released overnight rose. IGF-1 didn’t change, and neither did the measured amounts of muscle and fat.

Some strength and endurance tests improved, though others didn’t. It was a small study, so this isn’t a final verdict on adult treatment. The useful point is that hormone levels, body fat and physical performance are different outcomes. One moving in a hoped-for direction doesn’t mean the others came along.

2012

A related medicine

The thinking study used tesamorelin

A 2012 trial in older adults found an improvement on thinking tests in people with and without mild cognitive impairment. The medicine was tesamorelin, a related drug. It wasn’t Sermorelin.

The paper’s title uses the broader term “growth hormone-releasing hormone,” which makes the mix-up understandable. That’s the hormone signal these medicines resemble. But related medicines don’t automatically share clinical results. This study can’t stand in as evidence that Sermorelin improves memory, however tempting that shortcut may be.

Which result would matter in your life?

Is the goal better sleep, more energy or less body fat? Those are different goals, and each needs evidence that actually measured it. A rise in a blood hormone can’t answer all three at once.

Large, long-term trials haven’t settled Sermorelin’s adult wellness benefits or safety. Earlier, largely pediatric research reported flushing and injection-site pain; it can’t tell us every risk of prolonged adult use. The safety page goes further into that gap. The children’s studies explain the historical treatment, without filling in the missing adult answers.